FAPI PET/MRI scan for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial uses a new type of PET/MRI scan (called FAPI) to see how well it can find prostate cancer. It may help doctors learn about a different way to image the cancer. You can join if you already have a scheduled or recent PSMA PET scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with prostate cancer
- You are scheduled for or have had a standard PSMA PET scan within the last 4 weeks
- You are willing and able to have a PET/MRI scan for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan (PSMA PET) to check if prostate cancer returns after focused treatment (focal therapy). It may help find any remaining cancer that standard scans miss.
This early-phase study tests a special PET-MRI scan using rhPSMA-73 to better detect prostate cancer areas in men who would otherwise choose active surveillance. It may help doctors see where (and how much) cancer is present before deciding on treatment.
This study uses a special type of PET/CT scan (FAPI) to see if it can better detect where prostate cancer has spread in men with newly diagnosed, high-risk disease. It may help doctors plan more accurate treatment.
This study tests a new type of PET scan that uses a special tracer called FAPI to find where cancer has spread in your body. It may help doctors see hidden tumors more clearly without needing extra treatments first.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
This trial tests a new imaging method (FAPI PET/MRI) to see if it can help evaluate breast cancer. It focuses on people with invasive breast cancer who are about to start treatment before surgery or who have recurrent or new breast cancer.
Hear when a new Prostate Cancer Metastatic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.